Dicerna, Roche strike $1.67bn deal for hepatitis B virus therapies
Dicerna Pharmaceuticals has secured a research collaboration and licensing deal worth up to $1.67 billion with Roche to…
Amplia Pharmatek acquired by NuChem Therapeutics
NuChem Therapeutics has wrapped up the acquisition of Amplia Pharmatek, a Quebec-based drug discovery and development contract research…
LAVENDER phase 3 clinical trial launched for trofinetide in Rett syndrome by Acadia Pharmaceuticals
US biopharma company Acadia Pharmaceuticals has launched the LAVENDER phase 3 clinical trial to evaluate the efficacy and…
Cellectis begins MELANI-01 clinical trial for UCARTCS1 in multiple myeloma
Cellectis said that it has dosed the first patient in a phase 1 study – the MELANI-01 clinical…
Mirum gets FDA breakthrough therapy status for maralixibat for Alagille syndrome
Mirum Pharmaceuticals has secured the breakthrough therapy designation for maralixibat from the US Food and Drug Administration (FDA)…
Arena begins ADVISE clinical trial for etrasimod in atopic dermatitis
Arena Pharmaceuticals has dosed the first subject in the phase 2 ADVISE clinical trial, which is evaluating etrasimod…
Pepticom secures investment for AI-driven peptide drug discovery
Israel-based Pepticom, which is engaged in using artificial intelligence (AI) for peptide drug discovery, has raised $5 million in…
LIPAC Oncology takes NMIBC treatment TBC-1002 into phase 2 A trial
Investigational NMIBC treatment TBC-1002 : LIPAC Oncology said that it has wrapped up a phase 1 clinical trial…
Innovia Medical acquires surgical instruments manufacturer DTR Medical
Innovia acquisition of DTR Medical : Medical devices manufacturer Innovia Medical has acquired Wales-based DTR Medical, which designs…
Avrobio gets FDA orphan status for AVR-RD-02 in Gaucher disease
US gene therapy company Avrobio has secured orphan-drug designation for AVR-RD-02, its investigational gene therapy, for the treatment…